A
Anne M. Gillis
Researcher at University of Calgary
Publications - 135
Citations - 6254
Anne M. Gillis is an academic researcher from University of Calgary. The author has contributed to research in topics: Ventricular tachycardia & Atrial fibrillation. The author has an hindex of 35, co-authored 127 publications receiving 5759 citations. Previous affiliations of Anne M. Gillis include Cardiovascular Institute of the South & University of Bern.
Papers
More filters
Journal ArticleDOI
Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes
Stuart J. Connolly,Charles R. Kerr,Michael Gent,Robin S. Roberts,Salim Yusuf,Anne M. Gillis,Magdi Sami,Mario Talajic,Anthony S.L. Tang,George Klein,Ching Lau,David Newman +11 more
TL;DR: Physiologic pacing provides little benefit over ventricular pacing for the prevention of stroke or death due to cardiovascular causes and the effect on the rate of atrial fibrillation was not apparent until two years after implants.
Journal ArticleDOI
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Sana M. Al-Khatib,William G. Stevenson,Michael J. Ackerman,William J. Bryant,David J. Callans,Anne B. Curtis,Barbara J. Deal,Timm Dickfeld,Michael E. Field,Gregg C. Fonarow,Anne M. Gillis,Christopher B. Granger,Stephen C. Hammill,Mark A. Hlatky,Jose A. Joglar,G. Neal Kay,Daniel D. Matlock,Robert J. Myerburg,Richard L. Page +18 more
Journal ArticleDOI
HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations
Bruce L. Wilkoff,Angelo Auricchio,Josep Brugada,Martin R. Cowie,Kenneth A. Ellenbogen,Anne M. Gillis,David L. Hayes,Jonathan G. Howlett,Josef Kautzner,Charles J. Love,John M. Morgan,Silvia G. Priori,Dwight W. Reynolds,Mark H. Schoenfeld,Panos E. Vardas +14 more
TL;DR: This statement summarizes the opinion of the writing group members based on their own experience in treating patients, as well as a review of the literature, and is directed to all health care professionals, health care institutions, CIED manufacturers and governmental, reimbursement and regulatory bodies who are involved in the care of patients with CIEDs.
Journal Article
Noninvasive Risk Assessment Early After a Myocardial Infarction : The REFINE Study. Commentary
Derek V. Exner,Katherine M. Kavanagh,Michael P. Slawnych,L. Brent Mitchell,Darlene Ramadan,Sandeep Aggarwal,Catherine Noullett,Allie Van Schaik,Ryan T. Mitchell,Mariko A. Shibata,Sajad Gulamhussein,James McMeekin,Wayne Tymchak,Gregory Schnell,Anne M. Gillis,Robert S. Sheldon,Gordon H. Fick,Henry J. Duff,Peter Sleight +18 more
TL;DR: In this paper, the authors evaluated whether combined assessment of autonomic tone plus cardiac electrical substrate identifies most patients at risk of serious events after myocardial infarction (Ml) and to compare assessment at 2 to 4 weeks versus 10 to 14 weeks after Ml.
Journal ArticleDOI
HRS/EHRA expert consensus on the monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of techniques, indications, personnel, frequency and ethical considerations - Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC)
Bruce L. Wilkoff,Angelo Auricchio,Josep Brugada,Martin R. Cowie,Kenneth A. Ellenbogen,Anne M. Gillis,David L. Hayes,Jonathan G. Howlett,Josef Kautzner,Charles J. Love,John M. Morgan,Silvia G. Priori,Dwight W. Reynolds,Mark H. Schoenfeld,Panos E. Vardas,Donna M. Goldberg +15 more
TL;DR: Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart failure Society of America (HFSA).